Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
Butterfly Network Inc(BFLY)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for BFLY
09/17/2026: BFLY (1-star) is currently NOT-A-BUY. Pass it for now.
Butterfly Network is a health technology firm specializing in affordable, handheld ultrasound devices driven by its proprietary semiconductor-based Ultrasound-on-Chip technology. The company’s primary strength lies in its ability to provide portable diagnostic imaging at a lower price point than legacy systems, coupled with an AI-integrated software platform. Its growth story centers on expanding the reach of ultrasound into primary care and home settings. However, the company faces significant competition from well-capitalized imaging incumbents and high execution risk while scaling its operations to reach sustained profitability. Investors should monitor progress in subscription revenue growth and margin improvement, as the stock typically suits those with a higher risk tolerance.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company offers high growth potential in the POCUS sector but carries execution risks associated with scaling a niche technology. |
| Momentum investor | Strong fit while signal remains positive | Technical and product milestones often drive significant short-term interest in the stock price. |
| Value investor | Weak fit | The company is not currently valued on traditional earnings metrics, making it unsuitable for classic value strategies. |
| Dividend investor | Weak fit | The company does not pay a dividend and is focused on reinvesting capital for growth. |
| Low-risk investor | Weak fit | High volatility and the absence of established profitability make this a high-risk security. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock exhibits significant price swings characteristic of early-stage, growth-focused health technology equities. |
| Valuation risk | Medium / high | Market sentiment heavily influences valuation due to a lack of traditional earnings-based price support. |
| Competition risk (AI and Incumbent competition) | High | Large incumbents are actively launching portable ultrasound solutions that may challenge Butterfly's market share. |
| Business quality | Medium | While the core semiconductor technology is unique, the business model relies heavily on successful commercial adoption. |
| Dividend income | Low / none | The company retains all capital to fund product development and market expansion. |
| Execution risk | Medium / high | Successfully transitioning from a hardware-only company to a software-enabled enterprise requires sustained operational success. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit 4.05% | Avg. Invested days 25 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/17/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.93B USD | Price to earnings Ratio - | 1Y Target Price 10.67 |
Price to earnings Ratio - | 1Y Target Price 10.67 | ||
Volume (30-day avg) 4.8M shares | Beta 2.09 | 52 Weeks Range 1.81 - 10.05 | Updated Date 09/17/2026 |
52 Weeks Range 1.81 - 10.05 | Updated Date 09/17/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.27 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Hardware Sales | Direct sales of the Butterfly iQ ultrasound probes to clinicians and health systems. | Hardware sales drive initial adoption and user entry into the ecosystem. |
| Subscriptions | Recurring revenue from Butterfly Cloud and AI-enabled software features. | Subscriptions represent the high-margin, sticky revenue stream that supports long-term valuation. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE - | Enterprise Value 1.83B | Price to Sales(TTM) 17.24 |
Enterprise Value 1.83B | Price to Sales(TTM) 17.24 | ||
Enterprise Value to Revenue 17.58 | Enterprise Value to EBITDA -9.57 | Shares Outstanding 244.86M | Shares Floating 219.93M |
Shares Outstanding 244.86M | Shares Floating 219.93M | ||
Percent Insiders 10.26 | Percent Institutions 61.47 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About Butterfly Network Inc
Exchange NYSE | Headquarters Burlington, MA, United States | ||
IPO Launch date 2020-07-13 | CEO, President & Chairman of the Board Mr. Joseph M. DeVivo | ||
Sector Healthcare | Industry Medical Devices | Full time employees 220 | Website https://www.butterflynetwork.com |
Full time employees 220 | Website https://www.butterflynetwork.com | ||
Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. The company offers Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging on a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; Butterfly Move, merging the mobility of a handheld with the stability of a full cart system; and iQ+ Bladder, a specialty product for bladder scanning market. It also provides Compass AI which offers one system to connect every device, workflow, and department; ScanLab, an AI-powered educational platform that provides written walkthroughs and reference imagery to guide real-time educational scanning; and Butterfly iQ+/iQ3 Vet, a third generation handheld ultrasound system. It sells and markets its products through a direct sales force, distributors, and e-commerce channels. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.